Healthcare

Regis Healthcare Limited (ASX:REG) operates Australian residential aged care homes and related services, including home care, respite and retirement living. Its operating model combines care provision with accommodation and resident services, and financial outcomes depend on occupancy, staffing, operating costs and the regulatory framework …

Cochlear Limited (ASX:COH) designs and supplies implantable hearing devices, sound processors, related services and acoustic solutions for people with hearing loss. Its business comprises cochlear implants, services such as replacement sound processors, and acoustics products. Sales span the Americas, Europe, the Middle East, Africa …

Racura Oncology Limited (ASX:RAC) is an Australian clinical-stage oncology company developing RC220, a drug candidate under investigation in cancer treatment programs. Its activities are principally clinical research, manufacturing, regulatory work and patient recruitment rather than commercial drug sales. Clinical results determine whether development can …

Clinuvel Pharmaceuticals Limited (ASX:CUV) develops and commercialises therapies for selected genetic, metabolic and dermatological conditions. Its commercial product SCENESSE is used for eligible adults with erythropoietic protoporphyria, a disorder involving severe light sensitivity. The company also pursues programs addressing pigmentary and other disorders. Commercial …

Ryoncil is a commercial treatment associated with steroid-refractory acute graft-versus-host disease in paediatric patients. Alongside this marketed product, Mesoblast is developing therapies for chronic lower back pain and other conditions. The clinical programs have different development, regulatory andManufacturingrequirements from a product already generating sales.

The company operates in radiopharmaceutical development, where products combine a radioactive isotope with a targeted molecular agent. Diagnostic and therapeutic applications have different clinical objectives and regulatory requirements. Clarity is pursuing a number of programs, so results from one study should not be treated …

The company operates in sleep and breathing health across the Americas and other international markets. Device and mask sales are accompanied by residential-care software activities. The operating segments have differentRevenuedrivers, including equipment replacement, patient access, reimbursement, providerDemandand software subscriptions.